Risks and complications

In patients taking DOACs, a good piece of advice is to schedule surgery in the morning and delay drug intake until the evening.

In patients taking low-dose ARDs, implants can be placed when the duration of drug intake is under five years. Patients taking high-dose ARD treatment and who already have implants should be strictly monitored to prevent peri-implant inflammation.

To prevent misconceptions leading to a lack of satisfaction with treatment outcomes, patient expectations should be checked during the diagnostic phase. This is when appropriate information should be provided to and discussed with the patient. Although many methods are available and can contribute to effective communication, it appears that the role of face-to-face interaction is still irreplaceable.